IP Library Granted Patent US 10,125,376
Granted Patent B2
US 10,125,376 · App. 15/851,715 · Granted Nov 13, 2018

Microbial derived isoprene and methods for making the same

Inventor: Derek McPhee (Emeryville, CA)
Assignee: Amyris, Inc.
C12P5/007C07C7/09C07C11/16C12M47/20Y02E50/343
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,125,376
App. No.
15/851,715
Granted
Nov 13, 2018
Kind
B2
Abstract

Provided herein is a gaseous isoprene composition comprising isoprene, carbon dioxide and water, wherein the isoprene is in an amount between about 0.1% and about 15% by volume; wherein the carbon dioxide is in an amount between about 0.04% and about 35% by volume; wherein the water is in an amount greater than about 70% of its saturation amount. Also provided herein is a liquid isoprene composition comprising isoprene in an amount of at least 65% by weight and carbon dioxide in an amount between about 0.01% and about 1% by weight.

Claims (20)

1. A gaseous isoprene composition comprising isoprene, carbon dioxide and water, wherein the isoprene is present in an amount between about 0.1% and about 15% by volume; wherein the carbon dioxide is in an amount greater than about 0.04% by volume; wherein the water is in an amount greater than about 70% of its saturation amount; and wherein the gaseous isoprene composition comprises 1 part per million or less of C 2 -C 5 alkynes.

2. The gaseous isoprene composition of claim 1 , wherein the gaseous composition comprises less than about 3% by weight of water.

3. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises oxygen in an amount between about 1% and about 20% by volume.

4. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises nitrogen in an amount greater than about 50% by volume.

5. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises argon in an amount less than about 0.9% by volume.

6. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises argon in an amount greater than about 1.0% by volume.

7. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises ethanol in an amount less than about 0.5% by volume.

8. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises ethanol in an amount more than about 1% by volume.

9. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises 1 part per million or less of cyclopentadiene.

10. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises 1 part per million or less of piperylene.

11. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises 1 part per million or less of 1,4-pentadiene.

12. The gaseous isoprene composition of claim 1 , wherein the isoprene is present in an amount between about 1% and about 5% by volume.

13. The gaseous isoprene composition of claim 1 , wherein the isoprene is present in an amount between about 1% and about 10% by volume.

14. The gaseous isoprene composition of claim 1 , wherein the isoprene is present in an amount between about 5% and about 10% by volume.

15. The gaseous isoprene composition of claim 1 , wherein the carbon dioxide is present in an amount that is greater than about 5% by volume.

16. The gaseous isoprene composition of claim 1 , wherein the carbon dioxide is present in an amount that is greater than about 10% by volume.

17. The gaseous isoprene composition of claim 1 , wherein the carbon dioxide is present in an amount that is between about 1% and about 35% by volume.

18. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises oxygen in an amount less than about 5% by volume.

19. The gaseous isoprene composition of claim 1 , wherein the gaseous composition further comprises oxygen in an amount less than about 2% by volume.

20. The gaseous isoprene composition of claim 1 , wherein the gaseous isoprene composition is obtained by using a plurality of genetically modified host cells capable of making isoprene via the DXP and/or MEV pathway.

Assignments (10)
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2023
From: SCHOTTENFELD OPPORTUNITIES FUND II, L.P.
To: AMYRIS, INC.
Reel/Frame 062760/0818 →
RELEASE OF SECURITY INTEREST Recorded Feb 14, 2023
From: NAXYRIS S.A.
To: AMYRIS, INC.
Reel/Frame 062760/0753 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
GRANT OF PATENT SECURITY INTEREST Recorded Nov 20, 2019
From: AMYRIS, INC.
To: SCHOTTENFELD OPPORTUNITIES FUND II, L.P.
Reel/Frame 051072/0310 →
SECURITY INTEREST Recorded Aug 16, 2019
From: AMYRIS, INC.
To: NAXYRIS S.A.
Reel/Frame 050081/0106 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2017
From: MCPHEE, DEREK
To: AMYRIS BIOTECHNOLOGIES, INC.
Reel/Frame 044487/0281 →
CHANGE OF NAME Recorded Dec 27, 2017
From: AMYRIS BIOTECHNOLOGIES, INC.
To: AMYRIS, INC.
Reel/Frame 044961/0952 →
Continuity (6)
Continuation 14956402 · Dec 2, 2015
Division 13887381 · May 6, 2013
Division 13629623 · Sep 28, 2012
Division 12659216 · Mar 1, 2010
Provisional Application 61202474 · Mar 3, 2009
Related Publication 20180155741A1 · Jun 7, 2018